Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top

Head & Neck Oncology

2009 - 2012
Volumes
6
Issues
Chevron right icon
Issue 1/2012
Latest issue

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

About this journal

The official journal of the Head & Neck Optical Diagnostics Society.

Head & Neck Oncology encompasses all aspects of clinical practice, basic and translational research on the aetiology, pathophysiology, diagnosis, assessment, management, follow-up and prognosis of patients with head and neck tumours.

Metadata
Title
Head & Neck Oncology
Coverage
Volume 1/2009 - Volume 4/2012
Electronic ISSN
1758-3284
Journal ID
13051
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits